A sterile viscous/elastic solution or gel (e.g., comprised of hyaluronic acids and their polymeric derivatives) intended to be injected into joints (particularly large, load-bearing joints such as the hip or knee) to help cushion the joint, especially in cases
| Company | Devices | Share |
|---|---|---|
| Fcl Health Solutions Ltd | 8 | 8% |
| Acre Pharma Limited | 7 | 7% |
| Ally Medical Supplies Ltd | 7 | 7% |
| Nuvara Srl | 7 | 7% |
| Maplestone Developments Limited | 6 | 6% |
| Pavan Trading Ltd | 6 | 6% |
| Fidia Farmaceutici Spa | 6 | 6% |
| Propharma-Uk Ltd | 5 | 5% |
| Pharmaceutical Health Limited | 5 | 5% |
| Pharmamondis Gmbh | 5 | 5% |
| Saima Global Farma S.L. | 5 | 5% |
| Anika Therapeutics, Inc. | 4 | 4% |
Company = labeler of record on GUDID. 24 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| MOZ | Acid, Hyaluronic, Intraarticular | 112 |
| MOZ | Acid, hyaluronic, intraarticular | 9 |
| PKY | Implant, Dermal, For Aesthetic Use In The Hands | 1 |
| LMH | Implant, Dermal, For Aesthetic Use | 1 |
Use these as the dimensions to specify in a tender line.
No closely related category with 50+ devices.
95 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Synovial fluid supplementation medium", from 24 companies. The largest labeler is Fcl Health Solutions Ltd with 8% of records.
MOZ (Acid, Hyaluronic, Intraarticular), MOZ (Acid, hyaluronic, intraarticular), PKY (Implant, Dermal, For Aesthetic Use In The Hands), LMH (Implant, Dermal, For Aesthetic Use)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add synovial fluid supplementation medium to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.